tiziana-logo.png
Tiziana Life Sciences Announces Invitation for Podium Presentation of Research on Intranasal Anti-CD3 mAb in Intracerebral Hemorrhage at the Annual American Academy of Neurology Conference
April 04, 2023 10:43 ET | Tiziana Life Sciences Ltd.
Dr. Saef Izzy’s data shows one-month behavioral outcomes improvement in model of intracerebral hemorrhage (hemorrhagic stroke)Modulation of neuroinflammation by inducing FoxP3+ Tregs appears to have...
tiziana-logo.png
Tiziana Announces Positive Data on Intranasal Anti-CD3 Monoclonal Antibody in Intracerebral Hemorrhage
April 04, 2023 07:00 ET | Tiziana Life Sciences Ltd.
Tiziana planning to advance foralumab, the only fully human anti-CD3 monoclonal antibody, into human testing for hemorrhagic strokeData shows behavioral outcomes improvement at one month in model of...
A new collaboration between SNOMED International and ICH promotes seamless data exchange in support of public health
April 29, 2021 10:00 ET | SNOMED International
London, United Kingdom & Geneva, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- SNOMED International and the International Council for Harmonisation of Technical Requirements for...